Compare SER & GOAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SER | GOAI |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.4M | 62.0M |
| IPO Year | 2024 | 2023 |
| Metric | SER | GOAI |
|---|---|---|
| Price | $1.70 | $1.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | 28.7K | ★ 111.5K |
| Earning Date | 11-12-2026 | 11-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 966.67 |
| EPS | N/A | ★ N/A |
| Revenue | $130,000.00 | ★ $17,037,328.00 |
| Revenue This Year | N/A | $14.45 |
| Revenue Next Year | N/A | $53.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 132.14 | 82.59 |
| 52 Week Low | $1.22 | $1.42 |
| 52 Week High | $5.29 | $6.67 |
| Indicator | SER | GOAI |
|---|---|---|
| Relative Strength Index (RSI) | 35.23 | 36.08 |
| Support Level | $1.73 | $1.42 |
| Resistance Level | $1.86 | $2.66 |
| Average True Range (ATR) | 0.11 | 0.17 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 15.38 | 10.21 |
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.
Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.